ATEC
Price
$15.32
Change
+$0.35 (+2.34%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
2.22B
80 days until earnings call
XRAY
Price
$12.53
Change
-$0.44 (-3.40%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
2.59B
80 days until earnings call
Interact to see
Advertisement

ATEC vs XRAY

Header iconATEC vs XRAY Comparison
Open Charts ATEC vs XRAYBanner chart's image
Alphatec Holdings
Price$15.32
Change+$0.35 (+2.34%)
Volume$67.23K
Capitalization2.22B
DENTSPLY SIRONA
Price$12.53
Change-$0.44 (-3.40%)
Volume$93.11K
Capitalization2.59B
ATEC vs XRAY Comparison Chart in %
Loading...
ATEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATEC vs. XRAY commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATEC is a Hold and XRAY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (ATEC: $14.97 vs. XRAY: $12.96)
Brand notoriety: ATEC and XRAY are both not notable
ATEC represents the Medical/Nursing Services, while XRAY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ATEC: 81% vs. XRAY: 253%
Market capitalization -- ATEC: $2.27B vs. XRAY: $2.5B
ATEC [@Medical/Nursing Services] is valued at $2.27B. XRAY’s [@Pharmaceuticals: Other] market capitalization is $2.5B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.63B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.15B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.52B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATEC’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • ATEC’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATEC and XRAY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATEC’s TA Score shows that 5 TA indicator(s) are bullish while XRAY’s TA Score has 5 bullish TA indicator(s).

  • ATEC’s TA Score: 5 bullish, 4 bearish.
  • XRAY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ATEC is a better buy in the short-term than XRAY.

Price Growth

ATEC (@Medical/Nursing Services) experienced а +8.71% price change this week, while XRAY (@Pharmaceuticals: Other) price change was -9.37% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.03%. For the same industry, the average monthly price growth was +0.41%, and the average quarterly price growth was +3.73%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.86%. For the same industry, the average monthly price growth was -3.35%, and the average quarterly price growth was +2.88%.

Reported Earning Dates

ATEC is expected to report earnings on Oct 30, 2025.

XRAY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (-2.03% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+1.86% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($2.59B) has a higher market cap than ATEC($2.22B). ATEC YTD gains are higher at: 63.072 vs. XRAY (-30.315). XRAY has more cash in the bank: 1.27B vs. ATEC (157M). ATEC has less debt than XRAY: ATEC (587M) vs XRAY (2.42B).
ATECXRAYATEC / XRAY
Capitalization2.22B2.59B86%
EBITDA-46.79MN/A-
Gain YTD63.072-30.315-208%
P/E RatioN/AN/A-
Revenue682MN/A-
Total Cash157M1.27B12%
Total Debt587M2.42B24%
FUNDAMENTALS RATINGS
ATEC vs XRAY: Fundamental Ratings
ATEC
XRAY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
52100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3765
P/E GROWTH RATING
1..100
10088
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (5) in the Medical Specialties industry is significantly better than the same rating for ATEC (99). This means that XRAY’s stock grew significantly faster than ATEC’s over the last 12 months.

ATEC's Profit vs Risk Rating (52) in the Medical Specialties industry is somewhat better than the same rating for XRAY (100). This means that ATEC’s stock grew somewhat faster than XRAY’s over the last 12 months.

XRAY's SMR Rating (97) in the Medical Specialties industry is in the same range as ATEC (100). This means that XRAY’s stock grew similarly to ATEC’s over the last 12 months.

ATEC's Price Growth Rating (37) in the Medical Specialties industry is in the same range as XRAY (65). This means that ATEC’s stock grew similarly to XRAY’s over the last 12 months.

XRAY's P/E Growth Rating (88) in the Medical Specialties industry is in the same range as ATEC (100). This means that XRAY’s stock grew similarly to ATEC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATECXRAY
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
60%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
70%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
72%
Advances
ODDS (%)
Bullish Trend 15 days ago
85%
Bullish Trend 14 days ago
58%
Declines
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 4 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
55%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
ATEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GNSRX31.210.28
+0.91%
abrdn US Small Cap Equity R
ISFIX17.390.10
+0.58%
VY® Columbia Contrarian Core I
PNSAX76.48-0.02
-0.03%
Putnam Small Cap Growth A
TRQZX101.57-0.86
-0.84%
T. Rowe Price Mid-Cap Growth Z
HFDFX19.19-0.21
-1.08%
Hartford Schroders US MidCap Opps F

ATEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATEC has been loosely correlated with LAB. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATEC jumps, then LAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATEC
1D Price
Change %
ATEC100%
+0.47%
LAB - ATEC
44%
Loosely correlated
+1.16%
XRAY - ATEC
39%
Loosely correlated
-2.04%
TFX - ATEC
37%
Loosely correlated
+2.53%
DXCM - ATEC
34%
Loosely correlated
+3.22%
QGEN - ATEC
34%
Loosely correlated
-0.66%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
-2.04%
NVST - XRAY
54%
Loosely correlated
+0.75%
QDEL - XRAY
49%
Loosely correlated
-2.01%
KIDS - XRAY
47%
Loosely correlated
-1.51%
STE - XRAY
46%
Loosely correlated
+2.80%
AZTA - XRAY
43%
Loosely correlated
-0.34%
More